
TOFA
CAS No. 54857-86-2
TOFA ( RMI14514 | MDL14514 )
产品货号. M14977 CAS No. 54857-86-2
TOFA (RMI14514、MDL14514) 是乙酰辅酶A羧化酶-α (ACCA) 和脂肪酸合成的间接变构抑制剂。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥259 | 有现货 |
![]() ![]() |
5MG | ¥389 | 有现货 |
![]() ![]() |
10MG | ¥510 | 有现货 |
![]() ![]() |
25MG | ¥948 | 有现货 |
![]() ![]() |
50MG | ¥1596 | 有现货 |
![]() ![]() |
100MG | ¥3013 | 有现货 |
![]() ![]() |
200MG | ¥4447 | 有现货 |
![]() ![]() |
500MG | ¥7039 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称TOFA
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述TOFA (RMI14514、MDL14514) 是乙酰辅酶A羧化酶-α (ACCA) 和脂肪酸合成的间接变构抑制剂。
-
产品描述TOFA (RMI14514, MDL14514) is an indirect, allosteric inhibitor of Acetyl-CoA carboxylase-α (ACCA) and fatty acid synthesis; converted to TOFyl-CoA, exerts an allosteric inhibition on ACCA; lowers blood lipids and inhibits fatty acid synthesis with minimal effects on liver weight and liver fat content; also induces human cancer cell apoptosis through disturbing their fatty acid synthesis.
-
体外实验——
-
体内实验——
-
同义词RMI14514 | MDL14514
-
通路Metabolic Enzyme/Protease
-
靶点ACC
-
受体ACC1
-
研究领域——
-
适应症——
化学信息
-
CAS Number54857-86-2
-
分子量324.45498
-
分子式C19H32O4
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 34 mg/mL
-
SMILESCCCCCCCCCCCCCCOC1=CC=C(O1)C(=O)O
-
化学全称2-Furancarboxylic acid, 5-(tetradecyloxy)-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Parker RA, et al. J Med Chem. 1977 Jun;20(6):781-91.
2. McCune SA, et al. J Biol Chem. 1979 Oct 25;254(20):10095-101.
3. Wang C, et al. Biochem Biophys Res Commun. 2009 Jul 31;385(3):302-6.